Replies to post #42156 on Ayala Pharmaceuticals Inc (ADXS)

[Keithz]

Steve...the article doesn't have anything to do with a potential buyout for me. It's simply the behavior of the company since DOC leaving. The take down of the SP, the INTERIM CEO title, my feeling of a lack of urgency on the cash situation and moving timelines........I feel the tutes got restless and put pressure on the BOD to get to a sale so they can cash out...the last cash raise was it....I hope BLUE's $60 price comes true and that is still chump change for BP but I'd be more than happy with $30 Plus....the company has so much going on.....we'll be heading north soon....maybe we'll get a nice Christmas present this year

[fbg0316]

Steve, I agree that that article implied Lombardo is not selling the company and wants to stay in New Jersey a long time. However, he could have said that to send the signal that unless a buyer is willing to step up and pay an attractive price for ADXS/fair value at least in the $20s then the company is not for sale.

I don't think we will see another dilution, surely not at the current multi year low price. If you read the press release talking about Lombardo's new role, the Board made a comment that they now believe the CEO is aligned with the Board. I interpreted this to mean that O'Connor was not aligned with the Board, most likely because O'Connor was not creating value/not striking any monetary deals on our late stage assets while relying too much on diluting investors.